Further commentary on mitochondrial dysfunction in autism spectrum disorder: Assessment and treatment considerations

Journal of Autism and Developmental Disorders

Volumn 42, Issue 4, 2012, Pages 643-646

  Dager, Stephen R ^a,b,c   Corrigan, Neva M ^a   Estes, Annette ^b   Shaw, Dennis W W ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Washington   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Autism; Brain lactate; Developmental disorders; Mitochondrial disorders; MRI; MRS

Indexed keywords

LACTIC ACID; PROPOFOL;

ARTICLE; AUTISM; BIPOLAR DISORDER; BRAIN DISEASE; BRAIN MITOCHONDRION; CLINICAL ASSESSMENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FRAGILE X SYNDROME; GENETIC DISORDER; HETEROPLASMY; HUMAN; HYPERBARISM; LACTATE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETT SYNDROME; SENSITIVITY AND SPECIFICITY;

EID: 84859109659     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-011-1352-4     Document Type: Article

References (29)

1. Amundsen, L. B., Artru, A. A., Dager, S. R., Shaw, D. W. W., Friedman, S., Sparks, B., et al. (2005). Propofol sedation for longitudinal pediatric neuroimaging research. Journal of Neurosurg Anesthesiology, 17(4), 180-192. (Pubitemid 41395893)
2. Bianchi, M. C., Sgandurra, G., Tosetti, M., Battini, R., & Cioni, G. (2007). Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosciene Reports, 27(1-3), 69-85. (Pubitemid 46940946)
3. Coleman, M., & Blass, J. P. (1985). Autism and lactic acidosis. Journal of Autism and Developmental Disorders, 15(1), 1-8. (Pubitemid 15103074)
4. Correia, C., Coutinho, A. M., Diogo, L., Grazina, M., Marques, C., Miguel, T., et al. (2006). Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Journal of Autism and Developmental Disorders, 36(8), 1137-1140. (Pubitemid 46020366)
5. Corrigan, N. M., Richards, T. L., Friedman, S. D., Petropoulos, H., & Dager, S. R. (2010). Improving 1HMRSI measurement of cerebral lactate for clinical applications. Psychiatry Research Neuroimaging, 182(1), 40-47.
6. Corrigan, N. M., Shaw, D. W. W., Richards, T. L., Estes, A. M., Friedman, S. D., Petropoulos, H., et al. (2011). Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. doi: 10.1007/s10803-011-1216-y.
7. Dager, S. R. (2010). The vexing role of baseline: Implications for neuroimaging studies of panic disorder. International Journal of Psychophysiology, 78(1), 20-26.
8. Dager, S. R., & Steen, R. G. (1992). Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Neuropsychopharmacology, 6(4), 249-266.
9. Dager, S. R., Friedman, S. D., Heide, A., Layton, M. E., Richards, T., Artru, A., et al. (1999). Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactateinduced panic. Archieves of General Psychiatry, 56(1), 70-77. (Pubitemid 29055052)
10. Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., et al. (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Archieves of General Psychiatry, 61(5), 450-458. (Pubitemid 38620843)
11. Dager, S. R., Corrigan, N. M., Richards, T. L., & Posse, S. (2008). Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging, 19(2), 81-96.
12. Dager, S., Corrigan, N., Richards, T., & Shaw, D. (2011). Brain chemistry: Magnetic resonance spectroscopy. In D. Amaral, G. Dawson, & D. Geshwind (Eds.), Autism Spectrum Disorder. Oxford: Oxford University Press.
13. Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The early start denver model. Pediatrics, 125(1), e17-e23.
14. Friedman, S. D., Dager, S. R., Richards, T. L., Petropoulos, H., & Posse, S. (2000). Modeling brain compartmental lactate response to metabolic challenge: A feasibility study. Psychiatry Research, 98(1), 55-66. (Pubitemid 30119888)
15. Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., et al. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60(1), 100-107. (Pubitemid 36070652)
16. Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63(7), 786-794.
17. Granpeesheh, D., Tarbox, J., Dixon, D., Wilke, A. E., Allen, S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 265-268.
18. Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., et al. (2008). The in-depth evaluation of suspected mitochondrial disease. Molecular Genetics and Metabolism, 94(1), 16-37.
19. Jepson, B., Granpeesheh, D., Tarbox, J., Olive, M. L., Stott, C., Braud, S., et al. (2011). Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 41(5), 575-588.
20. Lyoo, I. K., Dager, S. R., Kim, J. E., Yoon, S. J., Friedman, S. D., Dunner, D. L., et al. (2010). Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology, 35(8), 1743-1750.
21. Morgan, P. (2007). When propofol is problematic. Paper presented at the12th annual joint winter meeting of the society of pediatric anesthesia and American academy of pediatrics., Phoenix, Arizona.
22. Oliveira, G., Diogo, L., Grazina, M., Garcia, P., Ataíde, A., Marques, C., et al. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47(3), 185-189. (Pubitemid 40277824)
23. Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., Haas, R., et al. (2009). A modern approach tothe treatment of mitochondrial disease. Current Treatment Options in Neurology, 11(6), 414-430.
24. Posse, S., Dager, S. R., Richards, T. L., Yuan, C., Ogg, R., Artru, A. A., et al. (1997). In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI). Magnetic Resonance in Medicine, 37(6), 858-865. (Pubitemid 27270762)
25. Ramocki, M. B., & Zoghbi, H. Y. (2008). Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature, 455(7215), 912-918.
26. Rossignol, D. A., & Bradstreet, J. J. (2008). Evidence of mitochondrial dysfunction in autism and implications for treatment. American Journal of Biochemistry and Biotechnology, 4(2), 208-217. (Pubitemid 351573654)
27. Rossignol, D. A., & Frye, R. E. (2011). Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy. Journal of Autism and Developmental Disorders. doi:10.1007/s10803-011- 1276-z.
28. Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, doubleblind, controlled trial. BMC Pediatrics, 9, 21.
29. Saneto, R. P., Friedman, S. D., & Shaw, D. W. W. (2008). Neuroimaging of mitochondrial disease. Mitochondrion, 8(5-6), 396-413.